ro glp 1 serena williams Inside Williams' partnership with for GLP-1s Serena Williams shares her journey

Thanks to a longstanding success story and the multitude of oral formulations that have been in clinical use for years, this segment of the market has an extensive infrastructure, a firmly established reputation and a notable portfolio that translates into overall efficacy

All health plan leaders interviewed were worried about the growth of GLP-1 meds for both clinical indications, with the surge in uptake overwhelming health plans ability to manage cost, the study observed

The two studies are being presented this week at the joint conference held by the Society for Cardiovascular Angiography & Interventions (SCAI) 2026 Scientific Sessions & Canadian Association of Interventional Cardiology (CAIC)

dont knock it till you try it lol

That is normal and healthy